Insight Genetics Promotes Four
News Feb 13, 2013
Insight Genetics has announced that it has promoted four of its team members:
• Brock Schweitzer, PhD, is now senior scientist;
• Rachel Skelton, PhD, was promoted to regulatory scientist I;
• Kasey Lawrence was named technology specialist; and
• JonEric Pettersson assumed a new role as manager of commercial development.
Since its founding in 2007, Insight Genetics has been dedicated to enabling precision medicine in cancer care. The company collaborates with researchers, clinicians, and drug developers to develop molecular diagnostics that aid physicians in precisely typing and effectively treating patients’ cancers.
“Brock, Rachel, Kasey and JonEric have brought a breadth of knowledge and expertise to Insight Genetics that has helped us consistently generate exceptional scientific results and inform our business development efforts,” said Christopher Callaghan, president and COO of Insight Genetics. “They have all made significant contributions to our company’s growth and been integral in advancing the field of personalized cancer care.”
Senior Scientist Schweitzer, who completed his post-doctoral research training in immune cell function at Vanderbilt University School of Medicine, plans and conducts laboratory research on Insight Genetics’ expanding array of diagnostic tests.
He also contributes to the company’s licensing of biomarkers and technologies, and supports planning and coordination of its academic, clinical and corporate partnerships.
Before joining Insight Genetics as scientist II in 2012, Schweitzer received his PhD in molecular genetics from University of Cincinnati College of Medicine.
As regulatory scientist I, Skelton works with clinicians, researchers and pharmaceutical companies to test patient samples for cancer-causing biomarkers within Insight Genetics’ CLIA-certified molecular diagnostic lab.
She also ensures scientific and regulatory compliance for all tests performed in the lab. Skelton joined Insight Genetics in July 2012 after receiving her PhD in cell and developmental biology from Vanderbilt University School of Medicine, where she became proficient in molecular diagnostics and genetic screening.
As a technology specialist, Lawrence oversees day-to-day operations and conducts research for clinical tests in development, while also managing data in the CLIA lab.
As in his previous role as research associate III, Lawrence will continue to use his research background to apply new techniques and technologies in the company’s diagnostic lab.
Prior to joining Insight Genetics, Lawrence worked as a research assistant at Vanderbilt University’s Division of Genetic Medicine and the Genome Sciences Resource. He holds a bachelor of science in biology from Tennessee Tech University.
Pettersson, as manager of commercial development, guides commercialization of the company’s products for cancer diagnosis and monitoring. He also will identify new diagnostic and partnership opportunities for Insight Genetics.
Pettersson joined Insight Genetics in 2007 and became the company’s senior associate of business development in 2011.
He holds a bachelor’s degree in business administration, with a focus on international business, from Belmont University.
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE